证券代码：600993 证券简称：马应龙 公告编号：临 2026-002 马应龙药业集团股份有限公司 关于控股子公司转让下属控股公司股权的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司控股子公司马应龙医管拟将其持有的北京医管 6,105.80 万元出资额 （占北京医管注册资本的 79.8411%）以 10,375.87 万元交易价格转让给卓准技术。 一、交易情况概述 为优化公司医疗产业结构，2026 年 3 月 27 日马应龙药业集团股份有限公司 （以下简称"马应龙"或"本公司"或"公司"）控股子公司马应龙医疗管理股 份有限公司（以下简称"马应龙医管"）与卓准技术有限公司（以下简称"卓准 技术"）签订《股权转让合同》，将其持有的北京马应龙长青医院管理有限公司 （以下简称"北京医管"或"标的公司"）6,105.80 万元出资额（占北京医管注 册资本的 79.8144%）转让给卓准技术，交易价格为 10,375.87 万元。 本次交易完成后，马应龙医管不再持有北京医管股份，北京医管及其控股子 公司北京马 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：600993 证券简称：马应龙 公告编号：临 2026-001 马应龙药业集团股份有限公司 关于延长部分子公司担保额度使用期限的公告 重要内容提示： 公司延长合并报表范围的子公司马应龙大药房、马应龙物流、马应龙医 管的担保额度使用期限至 2026 年 4 月 30 日。截至本公告披露日，公司对外担保 余额 10,065.66 万元，占公司最近一期经审计净资产的 2.48%。 一、担保情况概述 （一）前期担保情况 2025 年 4 月 1 日马应龙药业集团股份有限公司（以下简称"马应龙"或"公 司"）召开第十一届董事会第十八次会议，审议通过了《关于为子公司提供贷款 担保额度的议案》，同意为子公司提供合计 29,000 万元（含银行承兑汇票）（人 民币，下同）的担保额度，使用期限为 2025 年 4 月 1 日至 2026 年 3 月 31 日， 具体内容详见公司于 2025 年 4 月 3 日披露的《第十一届董事会第十八次会议决 议公告》（公告编号：临 2025-001） ...

Core Viewpoint - The article promotes the "Mayinglong Eight Treasure Whitening and Spot-Fading Essence Cream," highlighting its effectiveness in skin whitening and spot reduction while being cost-effective compared to international brands [14][21][44]. Group 1: Product Introduction - The product is a special cosmetic registered with the National Medical Products Administration, specifically designed for whitening and spot-fading [23]. - Mayinglong, known for its long history in skincare, has transitioned from its origins in eye medicine to developing a range of skincare products, including this essence cream [16][58]. Group 2: Product Efficacy - The essence cream combines various whitening ingredients to target different stages of melanin production, effectively reducing existing spots and preventing new ones [27][88]. - Clinical tests have shown that consistent use can lead to visible improvements in skin tone and texture, with users reporting a reduction in spot size and overall skin brightness [30][38]. Group 3: Competitive Pricing - The essence cream is priced affordably, with a promotional offer for a travel pack (5 x 8g) at only 99 yuan, significantly lower than many international brands that charge over 500 yuan for similar products [47][114]. - The cost per gram for the travel pack is approximately 2.475 yuan, making it a highly competitive option in the market [47]. Group 4: Additional Benefits - The cream not only focuses on whitening but also provides strong moisturizing effects, making it suitable for users with dry or aging skin [94][100]. - Ingredients like shea butter and glycerin are included for their hydrating properties, ensuring long-lasting moisture retention [101][106].

Core Viewpoint - The article highlights the historical significance and architectural features of the former site of the Mayinglong Eye Pharmacy, tracing its origins back to the Ming Dynasty and its evolution over the centuries [2]. Group 1: Historical Background - The Mayinglong Eye Pharmacy's origins can be traced back to the Wanli period of the Ming Dynasty, when the Ma family from Dingzhou created the "Eight Treasure Eye Medicine" [2]. - The pharmacy was established in Beijing by Ma Wanxing, who named it after his father, Ma Yinglong, following a family tradition [2]. - In 2011, the pharmaceutical techniques of Mayinglong were included in the non-material cultural heritage list of Xicheng District, emphasizing its historical importance [2]. Group 2: Architectural Features - The former pharmacy is located in a gray two-story building that occupies a significant portion of Manjia Hutong, with the current address being 52 Qianmen West River Street and 3 Manjia Hutong [2]. - The building features a brick-wood structure, with a clear stone plaque displaying "Mayinglong" and retains exquisite decorative brick carvings on the second-floor arched windows [2]. - Despite some windows and structures being blocked, the overall condition of the building is well-preserved [2].

Core Viewpoint - The article emphasizes the effectiveness and affordability of the "MAYINGLONG Eight Treasure Whitening and Spot-Fading Essence Cream," highlighting its unique formulation that targets melanin production and promotes skin whitening while being cost-effective compared to international brands [15][47][118]. Group 1: Product Introduction - The MAYINGLONG brand, known for its historical roots in eye care, has expanded into skincare, leveraging its 400-year heritage to develop effective products [17][60][67]. - The Eight Treasure Whitening and Spot-Fading Essence Cream is specifically designed to combat dark spots and promote skin whitening, backed by a special cosmetic registration certificate [24][22]. Group 2: Product Efficacy - The essence cream employs a comprehensive approach to address melanin production at various stages, ensuring effective whitening and preventing rebound darkening [28][90]. - Key ingredients include SEPIWHITE MSH, acetyl glucosamine, niacinamide, and leaf extract, each targeting different aspects of melanin synthesis [87][88]. Group 3: Moisturizing Properties - The cream not only focuses on whitening but also provides strong moisturizing effects, utilizing ingredients like shea butter and glycerin to enhance skin hydration and prevent dryness [102][109]. - Users can expect improved skin texture and hydration, making it suitable for those with dry or aging skin [111][113]. Group 4: Pricing and Value - The product is positioned as a cost-effective alternative to high-end brands, with a promotional price of approximately 99 yuan for a set of five 8g travel-sized jars, significantly lower than typical prices for similar products [51][116]. - The essence cream's price per gram is notably lower than that of many international brands, enhancing its appeal to budget-conscious consumers [47][118].

Core Insights - The core viewpoint of the article highlights the rapid growth and increasing adoption of alginate dressings in the medical field due to their superior properties such as high absorbency, breathability, and antibacterial effects, making them a preferred choice for wound care, especially for complex wounds like burns and ulcers [1][12]. Industry Overview - The alginate dressing industry in China has seen its market size grow from 335 million yuan in 2017 to an estimated 3.421 billion yuan by 2024, with a compound annual growth rate (CAGR) of 39.37% [1][12]. - By 2025, the market size is projected to reach approximately 3.783 billion yuan [1][12]. - Key growth drivers include an aging population, increased health awareness, advancements in medical technology, and a growing preference for biodegradable materials [1][12]. Industry Development History - The alginate dressing industry in China began in the late 1980s, initially dominated by traditional gauze and cotton pads [7]. - The introduction of alginate dressings was facilitated by foreign companies in the early 1990s, but market penetration remained low due to high costs and limited clinical awareness [7]. - Domestic companies have since made significant technological advancements, overcoming key production challenges [7]. Industry Supply Chain - The supply chain for alginate dressings includes upstream raw materials such as alginate, silver ions, calcium chloride, and collagen [9]. - The midstream involves the production and manufacturing of alginate dressings, while the downstream encompasses sales channels including pharmaceutical companies, hospitals, pharmacies, and e-commerce platforms [9]. Competitive Landscape - The competitive landscape features both domestic and foreign companies, with foreign firms like ConvaTec and Smith & Nephew holding significant market shares in high-end products [12]. - Domestic companies such as Ma Ying Long, Weigao Group, and Steady Medical are actively pursuing technological innovation and market expansion [12]. Industry Trends - The industry is expected to see a shift towards smart and functional products, integrating technologies like pH monitoring and drug release systems to enhance treatment precision [16]. - Demand is anticipated to grow in chronic wound management and high-end care scenarios, driven by rising chronic disease rates and the expanding medical aesthetics market [17]. - Future products will focus on low allergenicity, biocompatibility, and ease of use to cater to sensitive skin and complex wound needs [19].

Core Viewpoint - The article highlights the rapid rise of domestic brands in China, showcasing their improved quality, aesthetic appeal, and cost-effectiveness, which has led to a significant shift in consumer preferences towards domestic products [4][6]. Group 1: Rise of Domestic Brands - Domestic brands have transformed from being perceived as low-quality to becoming competitive with international brands, with numerous new brands emerging in the market [4]. - Brands like Ma Ying Long, Kang Xue, and Shi Lang are gaining popularity due to their professional expertise and effective products [5]. - The phrase "Made in China" now carries a more positive connotation, reflecting the quality and innovation of domestic products [6]. Group 2: Product Recommendations - The article lists several high-quality domestic products, emphasizing their affordability and effectiveness: - Shi Lang Anti-Hair Loss Shampoo: 69.9 yuan for 2 bottles, known for its oil control and anti-hair loss properties [10]. - Kang Xue Camellia Seed Oil: 89 yuan for 3 bottles, praised for its skin-nourishing benefits [41][59]. - Ma Ying Long Eye Cream and Eye Mask: Starting at 69 yuan, effective for tightening and reducing wrinkles around the eyes [62][82]. - Pian Zai Huang Pearl Cream: 49.9 yuan for 3 bottles, recognized for its moisturizing and skin-softening effects [85][98]. - Soft and comfortable underwear: 69 yuan for 2 pieces, noted for its comfort and shaping qualities [100][113]. - Cherry Red Coat: 159 yuan, stylish and suitable for winter [138][156]. - Fatty Oil Cream: 49 yuan for 3 bottles, effective for dry skin [159][184]. - Wo Pin Bluetooth Earphones: 89 yuan, offering high-quality sound and comfort [185][210].

Core Viewpoint - The article emphasizes the importance of early eye care to prevent wrinkles and maintain youthful skin, highlighting the effectiveness of a specific eye cream from the brand "Tonghua" under the company Mayinglong [6][41][62]. Group 1: Product Effectiveness - The "Tonghua Oat Peptide Anti-Wrinkle Eye Cream" is noted for its strong moisturizing and anti-wrinkle properties, with ingredients like oat peptide and proprietary extracts that enhance skin vitality [51][57][62]. - Users have reported significant improvements in fine lines and overall skin condition around the eyes, making it a competitive option against international brands [42][62][88]. - The eye cream is designed to be lightweight and non-greasy, ensuring it does not clog pores or cause milia [73][86]. Group 2: Brand Background - Mayinglong, known for its hemorrhoid cream, has a long history in the eye care industry, dating back to 1582, which adds credibility to its eye care products [20][24][36]. - The brand has shifted focus back to eye care, leveraging its historical expertise and modern scientific research collaborations with universities [33][36][102]. Group 3: Pricing and Promotions - The eye cream is currently offered at a promotional price of 99 yuan for two 20g bottles, significantly reduced from the original price of 169 yuan, making it an attractive deal for consumers [91][134]. - The promotion includes additional samples and products, enhancing the perceived value for customers [91][134].

Core Viewpoint - Wuhan Mayinglong Pharmacy has been penalized for violating medical insurance fund regulations, highlighting ongoing compliance issues within the company [1] Group 1: Incident Details - Wuhan Municipal Medical Insurance Bureau disclosed that Mayinglong Pharmacy's Chaoyang Street store engaged in fraudulent use of medical insurance cards, resulting in a violation amount of 7,256.6 yuan [1] - The Medical Insurance Bureau has mandated the recovery of the fraudulent amount and the termination of the medical service agreement with the pharmacy [1] Group 2: Previous Violations - This is not the first instance of Mayinglong Pharmacy facing penalties for medical insurance violations; in March 2025, the company’s Huiji store was found to have fabricated prescriptions, leading to a violation amount of 1,445,882.30 yuan [1] - Similar penalties were imposed, including the recovery of the fraudulent amount, termination of the service agreement, and a demerit point for the store manager [1]

Company Dynamics - Wuhan Municipal Medical Insurance Bureau disclosed a case of Wuhan Mayinglong Pharmacy Chain Co., Ltd. violating medical insurance fund usage regulations, involving a total of 7,256.6 yuan in improper medical insurance expenses [2] - The medical insurance department took actions including recovering the improper medical insurance expenses of 7,256.6 yuan and terminating the medical insurance service agreement with the pharmacy [2] - This is not the first instance of Mayinglong Pharmacy facing penalties for improper medical insurance usage; in March 2025, a similar case at its Huiji Pharmacy involved 1,445,882.30 yuan in improper expenses, leading to the same penalties [2]